Instil Bio, Inc.(TIL)

Biotechnology · Dallas, TX

$6.90-0.06 (-0.79%)

Delayed quote: Oct 6, 2026, 2:58 PM EDT

EV/EBITDA Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBITDA ratio is N/A as of 2026-10-06T19:03:43.653Z.

Stored calculation inputs

Calculation as of: 2026-10-06T19:03:43.653Z.

Quote observation: 2026-10-06T18:58:44.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 46,761,725
Total debt · period ending 2026-06-30: 3,670,000
Cash · period ending 2026-06-30: 5,541,000
TTM operating EBITDA · period ending 2026-06-30: -35,651,000

FMP input reference: 1639651ea08d8a43111aa8341d4d68762a5dc33ecadd1da8a92c037613eb041e

EV/Sales|P/E Ratio|EBITDA|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

TIL EV/EBITDA Ratio Metrics

EV/EBITDA RATIO

N/A

TIL Competitors' EV/EBITDA Ratio

TIL

Instil Bio, Inc.

Current

Market Cap

$46.76M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CELU

Celularity Inc.

vs TIL

Market Cap

$46.31M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LITS

Lite Strategy, Inc.

vs TIL

Market Cap

$47.81M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

HOWL

Werewolf Therapeutics, Inc.

vs TIL

Market Cap

$45.03M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SNWV

SANUWAVE Health Inc.

vs TIL

Market Cap

$44.46M

EV/EBITDA Ratio

24.06x

TTM Avg

28.58x

3Y Avg

33.75x

5Y Avg

33.75x

DRIO

DarioHealth Corp.

vs TIL

Market Cap

$44.31M

EV/EBITDA Ratio

N/A

TTM Avg

14.42x

3Y Avg

17.44x

5Y Avg

22.72x

APLM

Apollomics, Inc.

vs TIL

Market Cap

$49.32M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BSEM

BioStem Technologies, Inc.

vs TIL

Market Cap

$44.16M

EV/EBITDA Ratio

N/A

TTM Avg

7.89x

3Y Avg

10.87x

5Y Avg

10.87x

TELA

TELA Bio, Inc.

vs TIL

Market Cap

$49.44M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MBOT

Microbot Medical Inc.

vs TIL

Market Cap

$49.44M

EV/EBITDA Ratio

N/A

TTM Avg

310.55x

3Y Avg

191.07x

5Y Avg

171.86x

NAME	MARKET CAP	EV/EBITDA RATIO	TTM	3Y	5Y
Instil Bio, Inc. (TIL)	$46.76M	N/A	N/A	N/A	N/A
Celularity Inc. (CELU)vs ›	$46.31M	N/A	N/A	N/A	N/A
Lite Strategy, Inc. (LITS)vs ›	$47.81M	N/A	N/A	N/A	N/A
Werewolf Therapeutics, Inc. (HOWL)vs ›	$45.03M	N/A	N/A	N/A	N/A
SANUWAVE Health Inc. (SNWV)vs ›	$44.46M	24.06x	28.58x	33.75x	33.75x
DarioHealth Corp. (DRIO)vs ›	$44.31M	N/A	14.42x	17.44x	22.72x
Apollomics, Inc. (APLM)vs ›	$49.32M	N/A	N/A	N/A	N/A
BioStem Technologies, Inc. (BSEM)vs ›	$44.16M	N/A	7.89x	10.87x	10.87x
TELA Bio, Inc. (TELA)vs ›	$49.44M	N/A	N/A	N/A	N/A
Microbot Medical Inc. (MBOT)vs ›	$49.44M	N/A	310.55x	191.07x	171.86x

EV/EBITDA Ratio Formula & Definition

EV/EBITDA = Enterprise Value / EBITDA (TTM)

Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

EV/Sales P/E Ratio EBITDA All Metrics